Dmitry Aleksandrovich Zinovkin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dmitry Aleksandrovich Zinovkin has a total of 191 co-authors. Here are the top co-authors by number of shared publications:
- Zahidul Islam Pranjol
School of Life Sciences, University of Sussex
27 shared publications - Eldar Arkadievich Nadyrov
Gomel State Medical University
9 shared publications - Vladimir I. Nikolaev
Gomel State Medical University
5 shared publications - Elena Ivanovna Lebedeva
Vitebsk State Order of Peoplesβ Friendship Medical University
4 shared publications - Yulia Anatolievna Lyzikova
Gomel State Medical University
4 shared publications - Anatoly Tadeushevich Shchastniy
Vitebsk State Order of Peoplesβ Friendship Medical University
3 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published byΒ Frontiers Media SAΒ inΒ Frontiers in Immunology
- Vol.Β 17, 1876751
Cancer-associated fibroblasts and innate immune cells: orchestrators of the immunosuppressive tumor microenvironment
The tumor microenvironment (TME) represents a complex, dynamic, and heterogeneous system in which stromal and immune elements interact to influence tumor development and mechanisms of immune escape. Within the stromal compartment, cancer-associated fibroblasts (CAFs) have been identified as key mediators of immune regulation in the TME. Emerging evidence indicates that CAFs engage in extensive crosstalk with innate immune cell populationsβincluding myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), natural killer (NK) cells, mast cells, and dendritic cells (DCs). Through these interactions, CAFs contribute to the establishment and maintenance of an immunosuppressive milieu that supports tumor progression and facilitates immune evasion. This review summarizes the molecular interactions between CAFs and innate immune cells in the TME. It highlights how CAF-derived factors such as IL-6, TGF-Ξ², CXCL12, and CSF-1 regulate immune cell recruitment and polarization, promoting immunosuppression, tumor progression, angiogenesis, and metastasis. Additionally, feedback signals from immune cells further sustain CAF activation, creating a self-reinforcing immunosuppressive microenvironment. Elucidating these multidirectional interactions offers important insights into tumor biology and identifies promising therapeutic avenues. Targeting CAF-associated signaling pathways or interfering with CAFβimmune cell communication may help restore anti-tumor immune responses and improve the effectiveness of cancer immunotherapy strategies.
- 19 October 2026
- Published byΒ Frontiers Media SAΒ inΒ Frontiers in Immunology
- Vol.Β 17, 1876751
Open AccessCancer-associated fibroblasts and innate immune cells: orchestrators of the immunosuppressive tumor microenvironment
The tumor microenvironment (TME) represents a complex, dynamic, and heterogeneous system in which stromal and immune elements interact to influence tumor development and mechanisms of immune escape. Within the stromal compartment, cancer-associated fibroblasts (CAFs) have been identified as key mediators of immune regulation in the TME. Emerging evidence indicates that CAFs engage in extensive crosstalk with innate immune cell populationsβincluding myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), natural killer (NK) cells, mast cells, and dendritic cells (DCs). Through these interactions, CAFs contribute to the establishment and maintenance of an immunosuppressive milieu that supports tumor progression and facilitates immune evasion. This review summarizes the molecular interactions between CAFs and innate immune cells in the TME. It highlights how CAF-derived factors such as IL-6, TGF-Ξ², CXCL12, and CSF-1 regulate immune cell recruitment and polarization, promoting immunosuppression, tumor progression, angiogenesis, and metastasis. Additionally, feedback signals from immune cells further sustain CAF activation, creating a self-reinforcing immunosuppressive microenvironment. Elucidating these multidirectional interactions offers important insights into tumor biology and identifies promising therapeutic avenues. Targeting CAF-associated signaling pathways or interfering with CAFβimmune cell communication may help restore anti-tumor immune responses and improve the effectiveness of cancer immunotherapy strategies.
- Open Access
- 15 October 2026
- Published byΒ Gomel State Medical UniversityΒ inΒ Health and Ecology Issues
- Vol.Β 23 Β (3) , 57-66
Analysis of risk predictors for the recurrence of chronic recurrent cystitis in women
Objective.Β To identify risk factors for recurrent episodes of chronic relapsing cystitis (CRC) in women. Materials and methods. The study included 108 patients (women; median age 40.0 [28; 55.5] years old) with a confirmed diagnosis of chronic recurrent cystitis. Patients underwent a comprehensive set of diagnostic and therapeutic procedures in accordance with the clinical protocol for the diagnosis and treatment of adult patients with urological diseases -in health care provided in outpatient and inpatient settings at district, regional, and national healthcare facilities of the Republic of Belarus, approved by the Order of the Ministry of Health of the Republic of Belarus No. 920 dated 22.09.2011. And furthermore, the occurrence of chronic cystitis recurrences was monitored within a year, after which the patients were divided into two groups: a group with disease recurrence (study group) β27 patients and a group without recurrence of CRC (comparison group) β 81 patients. Results. Direct correlations were identified between lymphoid infiltration and stromal vascular congestion in bladder biopsy specimens (r s =0.71; ps =0.36; ps =0.51; p Conclusion.Β The identified associations between morphological changes in the urinary bladder (lymphoid infiltration, venous congestion and stasis, acanthotic strands) and pelvic varicosities, combined with their high prevalence (81.5%) in patients with recurrent CRC, indicate that these factors influence the likelihood of CRC recurrence. This necessitates appropriate diagnostic and therapeutic measures aimed at eliminating these risk factors to reduce the probability of CRC recurrence.
- 15 October 2026
- Published byΒ Gomel State Medical UniversityΒ inΒ Health and Ecology Issues
- Vol.Β 23 Β (3) , 57-66
Open AccessAnalysis of risk predictors for the recurrence of chronic recurrent cystitis in women
Objective.Β To identify risk factors for recurrent episodes of chronic relapsing cystitis (CRC) in women. Materials and methods. The study included 108 patients (women; median age 40.0 [28; 55.5] years old) with a confirmed diagnosis of chronic recurrent cystitis. Patients underwent a comprehensive set of diagnostic and therapeutic procedures in accordance with the clinical protocol for the diagnosis and treatment of adult patients with urological diseases -in health care provided in outpatient and inpatient settings at district, regional, and national healthcare facilities of the Republic of Belarus, approved by the Order of the Ministry of Health of the Republic of Belarus No. 920 dated 22.09.2011. And furthermore, the occurrence of chronic cystitis recurrences was monitored within a year, after which the patients were divided into two groups: a group with disease recurrence (study group) β27 patients and a group without recurrence of CRC (comparison group) β 81 patients. Results. Direct correlations were identified between lymphoid infiltration and stromal vascular congestion in bladder biopsy specimens (r s =0.71; ps =0.36; ps =0.51; p Conclusion.Β The identified associations between morphological changes in the urinary bladder (lymphoid infiltration, venous congestion and stasis, acanthotic strands) and pelvic varicosities, combined with their high prevalence (81.5%) in patients with recurrent CRC, indicate that these factors influence the likelihood of CRC recurrence. This necessitates appropriate diagnostic and therapeutic measures aimed at eliminating these risk factors to reduce the probability of CRC recurrence.
- Open Access
- 15 September 2026
- Published byΒ Frontiers Media SAΒ inΒ Frontiers in Immunology
- Vol.Β 17, 1939464
Editorial: The uterus immune microenvironment features in physiological and pathological conditions
A recurring lesson from this collection is that uterine immunity is inseparable from tissue architecture. Wang and colleagues [1] make the point vividly, combining single-cell and highresolution spatial transcriptomics of the postmenopausal vaginal wall to show that estrogen does not simply switch tissue on. Instead it drives the selective expansion of HAS1+ fibroblasts that gather around blood vessels with pericytes to form an organised perivascular reparative niche. The finding reframes hormone action as the assembly of a spatially defined multicellular structure rather than diffuse activation, and it offers a plausible reason why local estrogen helps some women with pelvic organ prolapse and not others. A similar theme of ordered remodeling runs through Waldmann and colleagues [2], who track how the uterus rebuilds itself after birth. Their analysis of human and mouse postpartum tissue identifies the mesometrial triangle as a distinct compartment where CD206-negative macrophages, CD8+ T cells and myofibroblasts assemble around the site of placental detachment, an inflammatory reaction deliberately walled off by a collagen capsule and tempered by IL-10 so that repair proceeds without fibrosis. Both papers argue that restraint, not just activation, is what healthy uterine immunity is made of.Two further studies show how that physiology can be monitored. Chueh and colleagues [3] followed cervical mucus across pregnancy in 133 women and found that the chemokines IP-10 and MIP-1Ξ² fall by roughly half from early to late gestation and track with mucus pH, pointing to a coordinated and non-invasively sampleable readout of gestational immune adaptation. Avalos and colleagues [4] add a variable few would have predicted: fetal sex. Placental extracellular vesicles from male and female pregnancies reprogrammed maternal monocytes along different metabolic lines, with female-derived vesicles favouring a tolerogenic, lipid-fuelled phenotype and male-derived vesicles a more inflammatory one. That the sex of the fetus should tune the mother's immunometabolism is the kind of result that should make us wary of treating pregnancy as a single, uniform immune state. It also carries a methodological warning that runs quietly through the whole collection: studies that pool male and female pregnancies, or that ignore where in the tissue a cell sits, may be averaging away the very signals they set out to find.If the healthy uterus is defined by restraint, implantation is where that restraint is negotiated most delicately, and two mechanistic studies here converge on the idea that stromal cells, not immune cells, hold the script. Zhu and colleagues [5] show that decidual stromal cells secrete highmolecular-weight hyaluronic acid through HAS2, and that this matrix signal, acting on CD44, coaxes peripheral natural killer cells into tissue-resident, low-cytotoxicity dNK1-like cells via a Wnt and FOSL2 axis. In spontaneous abortion that instruction is lost and the NK compartment tilts toward cytotoxicity. Chen and colleagues [6] tell a complementary story with the growth factor pleiotrophin, identifying it through shared analysis of recurrent implantation failure and recurrent pregnancy loss as a hub that drives decidualization and shapes the local immune milieu through IGF-2; silencing it in the mouse uterus impaired implantation, and IGF-2 supplementation rescued the defect. Both studies make a therapeutically attractive claim, that the endometrial stroma can be nudged toward tolerance rather than treated as inert scaffolding.The clinical papers in this group are more sober about how far such biology has travelled toward the bedside. Rodriguez and colleagues [7] sampled the embryo transfer catheter itself and found that a higher proportion of gamma-delta T cells associated with live birth while neutrophil enrichment tracked with failure, with modest discriminative power. It is a clever, low-cost idea, though the authors are appropriately careful that clinical utility is unproven in a cohort of 48. Fang and colleagues [8] mine recurrent miscarriage transcriptomes for a less familiar form of cell death, paraptosis, and nominate PCNPP3 and ELOA as biomarkers linked to decidual NK cells and macrophages. These bioinformatics-led studies are hypothesis generators, and their value will stand or fall on independent validation, a caveat several authors in this issue commendably make on their own behalf. Taken together, the four papers sketch a satisfying arc from mechanism to marker, but they also expose the field's central tension: the deepest biology comes from stromal and NK cell experiments in dishes and mice, while the human data remain observational and small. Closing that gap is the work that will decide whether any of these targets reaches a patient.The pathological pregnancy papers share a common shape: an interface molecule goes missing or misbehaves, and immune balance collapses. Huang and colleagues [9] report that the checkpoint ligand CD200 is downregulated in preeclamptic placenta, where it co-localises with CD68+ macrophages, and link its loss to systemic markers of organ injury, positioning it as both a candidate mechanism and a biomarker. Yin and colleagues [10] cast a wider molecular net, using machine learning across preeclampsia and fetal growth restriction datasets to argue that placental glycosylation genes, among them B3GNT2 and ST6GAL1, are shared drivers of immune imbalance in both conditions. Glycosylation is an underexplored layer of maternal-fetal signalling, and its appearance here as a common thread linking two disorders that frequently coexist is a useful reframing rather than a mere gene list.The two reviews in this section widen the lens further. Ma and colleagues [11] make a persuasive case that obstetric antiphospholipid syndrome should be understood as more than a clotting disorder, foregrounding complement activation, neutrophil extracellular traps and decidual NK and...
- 15 September 2026
- Published byΒ Frontiers Media SAΒ inΒ Frontiers in Immunology
- Vol.Β 17, 1939464
Open AccessEditorial: The uterus immune microenvironment features in physiological and pathological conditions
A recurring lesson from this collection is that uterine immunity is inseparable from tissue architecture. Wang and colleagues [1] make the point vividly, combining single-cell and highresolution spatial transcriptomics of the postmenopausal vaginal wall to show that estrogen does not simply switch tissue on. Instead it drives the selective expansion of HAS1+ fibroblasts that gather around blood vessels with pericytes to form an organised perivascular reparative niche. The finding reframes hormone action as the assembly of a spatially defined multicellular structure rather than diffuse activation, and it offers a plausible reason why local estrogen helps some women with pelvic organ prolapse and not others. A similar theme of ordered remodeling runs through Waldmann and colleagues [2], who track how the uterus rebuilds itself after birth. Their analysis of human and mouse postpartum tissue identifies the mesometrial triangle as a distinct compartment where CD206-negative macrophages, CD8+ T cells and myofibroblasts assemble around the site of placental detachment, an inflammatory reaction deliberately walled off by a collagen capsule and tempered by IL-10 so that repair proceeds without fibrosis. Both papers argue that restraint, not just activation, is what healthy uterine immunity is made of.Two further studies show how that physiology can be monitored. Chueh and colleagues [3] followed cervical mucus across pregnancy in 133 women and found that the chemokines IP-10 and MIP-1Ξ² fall by roughly half from early to late gestation and track with mucus pH, pointing to a coordinated and non-invasively sampleable readout of gestational immune adaptation. Avalos and colleagues [4] add a variable few would have predicted: fetal sex. Placental extracellular vesicles from male and female pregnancies reprogrammed maternal monocytes along different metabolic lines, with female-derived vesicles favouring a tolerogenic, lipid-fuelled phenotype and male-derived vesicles a more inflammatory one. That the sex of the fetus should tune the mother's immunometabolism is the kind of result that should make us wary of treating pregnancy as a single, uniform immune state. It also carries a methodological warning that runs quietly through the whole collection: studies that pool male and female pregnancies, or that ignore where in the tissue a cell sits, may be averaging away the very signals they set out to find.If the healthy uterus is defined by restraint, implantation is where that restraint is negotiated most delicately, and two mechanistic studies here converge on the idea that stromal cells, not immune cells, hold the script. Zhu and colleagues [5] show that decidual stromal cells secrete highmolecular-weight hyaluronic acid through HAS2, and that this matrix signal, acting on CD44, coaxes peripheral natural killer cells into tissue-resident, low-cytotoxicity dNK1-like cells via a Wnt and FOSL2 axis. In spontaneous abortion that instruction is lost and the NK compartment tilts toward cytotoxicity. Chen and colleagues [6] tell a complementary story with the growth factor pleiotrophin, identifying it through shared analysis of recurrent implantation failure and recurrent pregnancy loss as a hub that drives decidualization and shapes the local immune milieu through IGF-2; silencing it in the mouse uterus impaired implantation, and IGF-2 supplementation rescued the defect. Both studies make a therapeutically attractive claim, that the endometrial stroma can be nudged toward tolerance rather than treated as inert scaffolding.The clinical papers in this group are more sober about how far such biology has travelled toward the bedside. Rodriguez and colleagues [7] sampled the embryo transfer catheter itself and found that a higher proportion of gamma-delta T cells associated with live birth while neutrophil enrichment tracked with failure, with modest discriminative power. It is a clever, low-cost idea, though the authors are appropriately careful that clinical utility is unproven in a cohort of 48. Fang and colleagues [8] mine recurrent miscarriage transcriptomes for a less familiar form of cell death, paraptosis, and nominate PCNPP3 and ELOA as biomarkers linked to decidual NK cells and macrophages. These bioinformatics-led studies are hypothesis generators, and their value will stand or fall on independent validation, a caveat several authors in this issue commendably make on their own behalf. Taken together, the four papers sketch a satisfying arc from mechanism to marker, but they also expose the field's central tension: the deepest biology comes from stromal and NK cell experiments in dishes and mice, while the human data remain observational and small. Closing that gap is the work that will decide whether any of these targets reaches a patient.The pathological pregnancy papers share a common shape: an interface molecule goes missing or misbehaves, and immune balance collapses. Huang and colleagues [9] report that the checkpoint ligand CD200 is downregulated in preeclamptic placenta, where it co-localises with CD68+ macrophages, and link its loss to systemic markers of organ injury, positioning it as both a candidate mechanism and a biomarker. Yin and colleagues [10] cast a wider molecular net, using machine learning across preeclampsia and fetal growth restriction datasets to argue that placental glycosylation genes, among them B3GNT2 and ST6GAL1, are shared drivers of immune imbalance in both conditions. Glycosylation is an underexplored layer of maternal-fetal signalling, and its appearance here as a common thread linking two disorders that frequently coexist is a useful reframing rather than a mere gene list.The two reviews in this section widen the lens further. Ma and colleagues [11] make a persuasive case that obstetric antiphospholipid syndrome should be understood as more than a clotting disorder, foregrounding complement activation, neutrophil extracellular traps and decidual NK and...
- Open Access
- 13 August 2026
- Published byΒ Luchevaya DiagnostikaΒ inΒ Journal of radiology and nuclear medicine
- Vol.Β 107 Β (2) , 129-134
Sacral Tarlov cyst: analysis of a clinical case with multimodal imaging
Tarlov cysts (perineural cysts) were previously considered incidental ο¬ndings; however, current evidence indicates their clinical signiο¬cance: they are detected in 4.18% of the population, predominantly in the sacral spine (most commonly at the S2 level), with a higher prevalence in women than in men (5.84% versus 3.03%). Patient G., a 66-year-old woman, presented with severe right-sided lumbar pain (8β9 points according to numeric rating scale) radiating to the right buttock and shoulder, exacerbated by movement. Her medical history included chronic moderate back pain, dysuria (urinary frequency and sensation of incomplete bladder emptying), and osteoporosis (densitometry T-score β4.8). Physical examination revealed tenderness at paravertebral points of the lumbar spine and trigger points over the right latissimus dorsi muscle. Computed tomography (CT) of the lumbosacral spine showed two ο¬uid-density lesions (+9 to +14 HU) at the S1βS2 level, 34Γ18Γ21 and 6Γ7Γ7 mm in size, with indentation of the posterior margin of the S1 vertebral body; a 2-mm disc protrusion was noted at L4βL5. Magnetic resonance imaging (MRI) revealed cysts 30Γ21Γ25 and 10Γ9Γ9 mm in size, hypointense on T1-weighted and hyperintense on T2-weighted images, extending into the left intervertebral foramen with contact involving the nerve root. CT conο¬rmed the ο¬uid nature of the cysts and identiο¬ed bony indentation. MRI veriο¬ed characteristic signal features and excluded other differential diagnoses. The size of the dominant cyst (>15 mm) correlated with symptom presence. Following surgical treatment, positive clinical dynamics were observed: resolution of pain and dysuria, conο¬rming a causal relationship. Comprehensive imaging helps avoid diagnostic errors and guides appropriate management in patients presenting with radiculopathy and pelvic ο¬oor dysfunction.
- 13 August 2026
- Published byΒ Luchevaya DiagnostikaΒ inΒ Journal of radiology and nuclear medicine
- Vol.Β 107 Β (2) , 129-134
Open AccessSacral Tarlov cyst: analysis of a clinical case with multimodal imaging
Tarlov cysts (perineural cysts) were previously considered incidental ο¬ndings; however, current evidence indicates their clinical signiο¬cance: they are detected in 4.18% of the population, predominantly in the sacral spine (most commonly at the S2 level), with a higher prevalence in women than in men (5.84% versus 3.03%). Patient G., a 66-year-old woman, presented with severe right-sided lumbar pain (8β9 points according to numeric rating scale) radiating to the right buttock and shoulder, exacerbated by movement. Her medical history included chronic moderate back pain, dysuria (urinary frequency and sensation of incomplete bladder emptying), and osteoporosis (densitometry T-score β4.8). Physical examination revealed tenderness at paravertebral points of the lumbar spine and trigger points over the right latissimus dorsi muscle. Computed tomography (CT) of the lumbosacral spine showed two ο¬uid-density lesions (+9 to +14 HU) at the S1βS2 level, 34Γ18Γ21 and 6Γ7Γ7 mm in size, with indentation of the posterior margin of the S1 vertebral body; a 2-mm disc protrusion was noted at L4βL5. Magnetic resonance imaging (MRI) revealed cysts 30Γ21Γ25 and 10Γ9Γ9 mm in size, hypointense on T1-weighted and hyperintense on T2-weighted images, extending into the left intervertebral foramen with contact involving the nerve root. CT conο¬rmed the ο¬uid nature of the cysts and identiο¬ed bony indentation. MRI veriο¬ed characteristic signal features and excluded other differential diagnoses. The size of the dominant cyst (>15 mm) correlated with symptom presence. Following surgical treatment, positive clinical dynamics were observed: resolution of pain and dysuria, conο¬rming a causal relationship. Comprehensive imaging helps avoid diagnostic errors and guides appropriate management in patients presenting with radiculopathy and pelvic ο¬oor dysfunction.
- Open Access
- 30 April 2026
- Published byΒ Wolters Kluwer HealthΒ inΒ Lung India
- Vol.Β 43 Β (3) , 349-350
Spontaneous lung herniation due to congenital rib hypoplasia in an elderly patient
- 30 April 2026
- Published byΒ Wolters Kluwer HealthΒ inΒ Lung India
- Vol.Β 43 Β (3) , 349-350
Open AccessSpontaneous lung herniation due to congenital rib hypoplasia in an elderly patient
- Open Access
Cathepsin L as a Driver of Tumour Invasion and a Novel Therapeutic Target in Ovarian Cancer
Ovarian cancer is the most lethal gynaecological cancer, largely because it is often diagnosed late and shows strong tumour heterogeneity, therapy resistance, and rapid metastatic spread. A key driver of this aggressive behaviour is the tumourβs ability to reshape its surrounding microenvironment to support invasion, angiogenesis, and escape from treatment. Cathepsin L (CTSL), a lysosomal cysteine protease, has emerged as an important mediator of these processes and is gaining attention as both a prognostic marker and a potential therapeutic target. This review examines the diverse roles of CTSL in ovarian cancer progression, focusing on how its expression, localisation, and extracellular release are altered within the hypoxic and acidic conditions typical of the tumour microenvironment. It also outlines emerging therapeutic strategies aimed at targeting CTSL, including selective inhibitors, multi-cathepsin approaches, CTSL-activated prodrugs and antibody-drug conjugate linkers, and nanomedicine systems designed for tumour-specific delivery. Overall, the evidence highlights CTSL as a central regulator of invasion, angiogenesis, and relapse in ovarian cancer, underscoring its potential as a target for new therapies in aggressive disease.
Open AccessCathepsin L as a Driver of Tumour Invasion and a Novel Therapeutic Target in Ovarian Cancer
Ovarian cancer is the most lethal gynaecological cancer, largely because it is often diagnosed late and shows strong tumour heterogeneity, therapy resistance, and rapid metastatic spread. A key driver of this aggressive behaviour is the tumourβs ability to reshape its surrounding microenvironment to support invasion, angiogenesis, and escape from treatment. Cathepsin L (CTSL), a lysosomal cysteine protease, has emerged as an important mediator of these processes and is gaining attention as both a prognostic marker and a potential therapeutic target. This review examines the diverse roles of CTSL in ovarian cancer progression, focusing on how its expression, localisation, and extracellular release are altered within the hypoxic and acidic conditions typical of the tumour microenvironment. It also outlines emerging therapeutic strategies aimed at targeting CTSL, including selective inhibitors, multi-cathepsin approaches, CTSL-activated prodrugs and antibody-drug conjugate linkers, and nanomedicine systems designed for tumour-specific delivery. Overall, the evidence highlights CTSL as a central regulator of invasion, angiogenesis, and relapse in ovarian cancer, underscoring its potential as a target for new therapies in aggressive disease.
- Open Access
- 16 April 2026
- Published byΒ Gomel State Medical UniversityΒ inΒ Health and Ecology Issues
- Vol.Β 23 Β (1) , 35-42
Spontaneous pneumothorax: features of its occurrence and course in patients treated over a three-year period in a thoracic surgery department
Objective . To consider currently known theories of spontaneous pneumothorax (SP). To study gender and age structure of the SP patient group, and to identify common patterns in the course of SP among patients in Gomel and the Gomel region. Materials and methods . Literary data on the genesis of SP were analyzed. A retrospective analysis of 226 medical records of hospital patients treated for SP at the surgical thoracic department of the Gomel Regional Clinical Hospital in the period 2019β2021 was conducted. A comparative assessment of patientsβ social, anthropometric, epidemiological, and clinical data was conducted. The obtained data were processed in the STATISTICA 10.0 software package using descriptive statistics. Results . The gender and age distribution of patients with SP was determined. Males with an average age of 36,1 (95% CI 34.2 β 38.0, SD=14.6) in a formed group predominated (79.6%). It was found out that patients with primary spontaneous pneumothorax (PSP) were more common than secondary spontaneous pneumothorax (88% and 12%, respectively). Patients with a normal body mass index (BMI) predominated in the group, median value complied 20,4Β±3,2 kg/mΒ². Other constitutional features important for determining the dysplastic phenotype could not be clarified within the retrospective study. The vast majority of patients had no precursors or trigger factors for the development of SP. Individual patients noted lifting weights the day before the onset of SP (n=11), training in the gym with strength exercises the day before SP or long-distance running (n=7), as well as presence of acute respiratory disease in a medical history (n 19) among the provoking factors. The majority of patients had right-sided SP (n=176; 77.9%) with the rupture localized in the S1-S2 segments. Macroscopic and microscopic histological material is shown signs of the bullous emphysema in 198 (87,6%) cases. Conclusion . This study analyzes existing working hypotheses regarding the causes of SP. Gender and age structure of the patients with SP in the case of 226 patients treated at hospitals over a three-year period. PSP was more frequently diagnosed in young men in the study group that corresponds to published data. The frequency of occurrence and nosological forms of secondary SP were identified, among which chronic obstructive pulmonary disease predominated; secondary SP was significantly more common in elderly patients. The right-sided localization of the process with damage to the apical segments of the lungs prevailed. Multiple bullae that were not detected on X-ray images of the lungs were revealed in the vast majority of patients during the histological examination of lung tissue resected during surgical intervention. The volume of SP prior to surgical treatment amounted to a half of normal. Analysis of medical records revealed a lack of data for evaluation of the dysplastic phenotype of the patients according to the current criteria. A prospective study is needed for a detailed and comprehensive study of the role of connective tissue dysplasia in the development of SP, as well as the presence of histological markers indicating connective tissue dysfunction and fibrosis.
- 16 April 2026
- Published byΒ Gomel State Medical UniversityΒ inΒ Health and Ecology Issues
- Vol.Β 23 Β (1) , 35-42
Open AccessSpontaneous pneumothorax: features of its occurrence and course in patients treated over a three-year period in a thoracic surgery department
Objective . To consider currently known theories of spontaneous pneumothorax (SP). To study gender and age structure of the SP patient group, and to identify common patterns in the course of SP among patients in Gomel and the Gomel region. Materials and methods . Literary data on the genesis of SP were analyzed. A retrospective analysis of 226 medical records of hospital patients treated for SP at the surgical thoracic department of the Gomel Regional Clinical Hospital in the period 2019β2021 was conducted. A comparative assessment of patientsβ social, anthropometric, epidemiological, and clinical data was conducted. The obtained data were processed in the STATISTICA 10.0 software package using descriptive statistics. Results . The gender and age distribution of patients with SP was determined. Males with an average age of 36,1 (95% CI 34.2 β 38.0, SD=14.6) in a formed group predominated (79.6%). It was found out that patients with primary spontaneous pneumothorax (PSP) were more common than secondary spontaneous pneumothorax (88% and 12%, respectively). Patients with a normal body mass index (BMI) predominated in the group, median value complied 20,4Β±3,2 kg/mΒ². Other constitutional features important for determining the dysplastic phenotype could not be clarified within the retrospective study. The vast majority of patients had no precursors or trigger factors for the development of SP. Individual patients noted lifting weights the day before the onset of SP (n=11), training in the gym with strength exercises the day before SP or long-distance running (n=7), as well as presence of acute respiratory disease in a medical history (n 19) among the provoking factors. The majority of patients had right-sided SP (n=176; 77.9%) with the rupture localized in the S1-S2 segments. Macroscopic and microscopic histological material is shown signs of the bullous emphysema in 198 (87,6%) cases. Conclusion . This study analyzes existing working hypotheses regarding the causes of SP. Gender and age structure of the patients with SP in the case of 226 patients treated at hospitals over a three-year period. PSP was more frequently diagnosed in young men in the study group that corresponds to published data. The frequency of occurrence and nosological forms of secondary SP were identified, among which chronic obstructive pulmonary disease predominated; secondary SP was significantly more common in elderly patients. The right-sided localization of the process with damage to the apical segments of the lungs prevailed. Multiple bullae that were not detected on X-ray images of the lungs were revealed in the vast majority of patients during the histological examination of lung tissue resected during surgical intervention. The volume of SP prior to surgical treatment amounted to a half of normal. Analysis of medical records revealed a lack of data for evaluation of the dysplastic phenotype of the patients according to the current criteria. A prospective study is needed for a detailed and comprehensive study of the role of connective tissue dysplasia in the development of SP, as well as the presence of histological markers indicating connective tissue dysfunction and fibrosis.
- Open Access
- 1 December 2025
- Published byΒ Maad Rayan Publishing CompanyΒ inΒ International Journal of Infectious Diseases
- Vol.Β 28 Β (12) , 719-722
Pancreatic PEComa: Case Report of an Extremely Rare Tumor
Pancreatic perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms with only a few reported cases. Their non-specific clinical presentations and imaging features often lead to misdiagnosis. We report a case of a 63-year-old female with intermittent left upper quadrant pain. Imaging revealed a hypervascular mass in the pancreatic tail, initially suspected to be a neuroendocrine tumor. The patient underwent distal pancreatectomy with splenectomy. Histopathological examination showed that the tumor consisted of epithelioid and spindle cells with clear cytoplasm, a rich vascular network and low mitotic activity. Immunohistochemically, the tumor cells were positive for HMB-45, Melan-A, and smooth muscle actin, confirming the diagnosis of pancreatic PEComa. The postoperative course was uneventful. Given the uncertain malignant potential of PEComas, complete surgical excision is the preferred treatment option, with long-term follow-up recommended. This case highlights the diagnostic challenges of pancreatic PEComas and underscores the role of histopathology and immunohistochemistry in their accurate identification and management.
- 1 December 2025
- Published byΒ Maad Rayan Publishing CompanyΒ inΒ International Journal of Infectious Diseases
- Vol.Β 28 Β (12) , 719-722
Open AccessPancreatic PEComa: Case Report of an Extremely Rare Tumor
Pancreatic perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms with only a few reported cases. Their non-specific clinical presentations and imaging features often lead to misdiagnosis. We report a case of a 63-year-old female with intermittent left upper quadrant pain. Imaging revealed a hypervascular mass in the pancreatic tail, initially suspected to be a neuroendocrine tumor. The patient underwent distal pancreatectomy with splenectomy. Histopathological examination showed that the tumor consisted of epithelioid and spindle cells with clear cytoplasm, a rich vascular network and low mitotic activity. Immunohistochemically, the tumor cells were positive for HMB-45, Melan-A, and smooth muscle actin, confirming the diagnosis of pancreatic PEComa. The postoperative course was uneventful. Given the uncertain malignant potential of PEComas, complete surgical excision is the preferred treatment option, with long-term follow-up recommended. This case highlights the diagnostic challenges of pancreatic PEComas and underscores the role of histopathology and immunohistochemistry in their accurate identification and management.
- Open Access
- 13 June 2025
- Published byΒ Vitebsk State Medical UniversityΒ inΒ Vestnik of Vitebsk State Medical University
- Vol.Β 24 Β (3) , 18-25
THE CORRELATIONS BETWEEN PARAMETERS OF THE VASCULAR COMPONENT AND SIGNAL MOLECULES OF THE EXTRACELLULAR MATRIX OF THE TUMOUR MICROENVIRONMENT OF ENDOMETRIOID ADENOCARCINOMA OF THE UTERINE BODY IN DIFFERENT DISEASE OUTCOMES
Objectives. To identify the correlations within the tumor microenvironment of endometrioid adenocarcinoma between the vascular component parameters and extracellular matrix signaling molecules in different disease outcomes. Material and methods. Histological archival material of 188 cases of the endometrioid adenocarcinoma of the uterine body was used in the study. The group with favorable outcome included 148 cases without tumour progression. The group with unfavorable outcome included 40 patients who had disease progression during the follow-up. CD105+, CD146+ vessels and vasculogenic mimicry in 1 mm2 of tumour were counted. Fibulin-1 and BMP-4 expression was assessed by semi-quantitative method. Spearmanβs test was used to identify correlations. When testing statistical hypotheses in this study, p was taken as 0.05. Results. In the group with unfavorable outcome of the endometrioid adenocarcinoma of the uterine body, weak direct correlations were observed between CD105+ microcirculatory vessels and vasculogenic mimicry (r=0.43 CI 0.13-0.65; p=0.006), and between Fibulin-1 expression and CD146+ vessels surrounded by vascular tumour-associated fibroblasts (r=0.35; p=0.026). In the group with favorable outcome, moderate correlations were found between CD105+ vessels and FIGO stage (r=0.63; p<0.001), and inverse correlations between vasculogenic mimicry and BMP-4 (r=-0.51; p<0.001). Conclusions. The established correlations may indicate remodeling of the vascular component of the tumour microenvironment and altered expression of extracellular matrix signalling molecules, possibly leading to changes in the biological potential of endometrioid adenocarcinoma of the uterine body in cases of unfavorable disease outcome.
- 13 June 2025
- Published byΒ Vitebsk State Medical UniversityΒ inΒ Vestnik of Vitebsk State Medical University
- Vol.Β 24 Β (3) , 18-25
Open AccessTHE CORRELATIONS BETWEEN PARAMETERS OF THE VASCULAR COMPONENT AND SIGNAL MOLECULES OF THE EXTRACELLULAR MATRIX OF THE TUMOUR MICROENVIRONMENT OF ENDOMETRIOID ADENOCARCINOMA OF THE UTERINE BODY IN DIFFERENT DISEASE OUTCOMES
Objectives. To identify the correlations within the tumor microenvironment of endometrioid adenocarcinoma between the vascular component parameters and extracellular matrix signaling molecules in different disease outcomes. Material and methods. Histological archival material of 188 cases of the endometrioid adenocarcinoma of the uterine body was used in the study. The group with favorable outcome included 148 cases without tumour progression. The group with unfavorable outcome included 40 patients who had disease progression during the follow-up. CD105+, CD146+ vessels and vasculogenic mimicry in 1 mm2 of tumour were counted. Fibulin-1 and BMP-4 expression was assessed by semi-quantitative method. Spearmanβs test was used to identify correlations. When testing statistical hypotheses in this study, p was taken as 0.05. Results. In the group with unfavorable outcome of the endometrioid adenocarcinoma of the uterine body, weak direct correlations were observed between CD105+ microcirculatory vessels and vasculogenic mimicry (r=0.43 CI 0.13-0.65; p=0.006), and between Fibulin-1 expression and CD146+ vessels surrounded by vascular tumour-associated fibroblasts (r=0.35; p=0.026). In the group with favorable outcome, moderate correlations were found between CD105+ vessels and FIGO stage (r=0.63; p<0.001), and inverse correlations between vasculogenic mimicry and BMP-4 (r=-0.51; p<0.001). Conclusions. The established correlations may indicate remodeling of the vascular component of the tumour microenvironment and altered expression of extracellular matrix signalling molecules, possibly leading to changes in the biological potential of endometrioid adenocarcinoma of the uterine body in cases of unfavorable disease outcome.
- Open Access
The Immunomodulatory Role of Galectin-1 in the Tumour Microenvironment and Strategies for Therapeutic Applications
With the morbidity of cancer currently on a perpetual rise, there is a critical need for new treatment options. Current therapeutic options, such as chemotherapy and radiotherapy, are frequently employed; however, the high rate of recurrence underscores the incomplete understanding of tumour growth, progression, and the intricacies of their microenvironments. In this study, we review the roles that galectin-1 (Gal1) plays in suppressing immune surveillance in the tumour microenvironment. Studies have shown that Gal1 changes the immune system parameters: suppressing T cell function, sensitising resting T lymphocytes to Fas/FasL, decreasing cell proliferation, reducing adhesion to extracellular matrix, inhibiting Th1 cytokines, increasing M2 phenotype macrophages, and promoting angiogenesis. Gal1 has garnered increasing attention as a potential therapeutic target due to its involvement in tumour progression and immune evasion. Given the limitations and toxic side effects associated with current treatment options, alternative strategies targeting Gal1 have been explored for their therapeutic potential. Approaches such as OTX008, anti-Gal1 monoclonal antibodies, and Gal1-targeted vaccines have demonstrated the ability to downregulate tumour progression by inhibiting Gal1 activity. These findings highlight the therapeutic promise of Gal1 not only as a novel target for cancer therapy but also as a potential prognostic biomarker, offering opportunities for the development of more effective and less toxic treatment strategies.
Open AccessThe Immunomodulatory Role of Galectin-1 in the Tumour Microenvironment and Strategies for Therapeutic Applications
With the morbidity of cancer currently on a perpetual rise, there is a critical need for new treatment options. Current therapeutic options, such as chemotherapy and radiotherapy, are frequently employed; however, the high rate of recurrence underscores the incomplete understanding of tumour growth, progression, and the intricacies of their microenvironments. In this study, we review the roles that galectin-1 (Gal1) plays in suppressing immune surveillance in the tumour microenvironment. Studies have shown that Gal1 changes the immune system parameters: suppressing T cell function, sensitising resting T lymphocytes to Fas/FasL, decreasing cell proliferation, reducing adhesion to extracellular matrix, inhibiting Th1 cytokines, increasing M2 phenotype macrophages, and promoting angiogenesis. Gal1 has garnered increasing attention as a potential therapeutic target due to its involvement in tumour progression and immune evasion. Given the limitations and toxic side effects associated with current treatment options, alternative strategies targeting Gal1 have been explored for their therapeutic potential. Approaches such as OTX008, anti-Gal1 monoclonal antibodies, and Gal1-targeted vaccines have demonstrated the ability to downregulate tumour progression by inhibiting Gal1 activity. These findings highlight the therapeutic promise of Gal1 not only as a novel target for cancer therapy but also as a potential prognostic biomarker, offering opportunities for the development of more effective and less toxic treatment strategies.